Table 1.
Expression of IGF2BP2 according to clinicopathological features of 60 pancreatic cancer patients
Characteristic | High | Low | P-value |
---|---|---|---|
Age | 31 | 29 | 0.586 |
≥ 65 years | 16 | 17 | |
< 65 years | 15 | 12 | |
Sex | 32 | 28 | 0.63 |
Male | 21 | 20 | |
Female | 11 | 8 | |
Grade | 0.034* | ||
Good | 2 | 3 | |
Moderate | 19 | 10 | |
Poor | 23 | 3 | |
TNM | 0.02* | ||
I&II | 22 | 12 | |
III&IV | 9 | 17 | |
Size | < 0.001* | ||
≥ 2.5 cm | 20 | 8 | |
< 2.5 cm | 9 | 23 | |
CA199 | 0.342 | ||
≥ 100 | 33 | 10 | |
< 100 | 11 | 6 |
*Statistical significant difference